Table 1_Efgartigimod combined with steroids as a fast-acting therapy for anti-SRP immune-mediated necrotizing myopathy.doc by Qiqi Peng (6560057)

“…</p>Results<p>Following one cycle of efgartigimod treatment (administered at a dosage of 10 mg/kg, once a week for a total of 4 injections in one period) in these three patients, CK values decreased by 79.30, 95.80, and 93.62%, respectively. …”

Supplementary file 1_Case Report: A case of reversible tracheal diameter Mounier-Kuhn syndrome and literature review.docx by Lu-xia Kong (21191087)

“…We encountered an 81-year-old male MKS patient whose diagnosis was delayed, and subsequently experienced a significant decrease in tracheal diameter post-diagnosis, marking the first documented case of reversible tracheal diameter in MKS patients. …”

Gene expression of neurotransmitter pathways at 6 dp. by Morgan Barnes (7876373)

“…In the 24 hpf dnVDRa induced group we see a significant decrease in glyt1 expression (p < 0.05) and an increase in glyt2 expression (p < 0.05) and in slc32a1 expression (p < 0.01). …”

Quantification of faecal glucocorticoid metabolites as a measure of stress in the rock hyrax (Procavia capensis) living in an urban green space by Scheun, Juan (8229483)

“…Animal FID did not differ significantly between seasons but they did differ significantly between sections, and decreased in accordance with fGCM concentrations. …”

PCAIs inhibit NCI-H23 cell line viability. by Matthew D. Gregory (19929096)

“…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”

PCAIs disrupt actin filaments in NCI-H23 cells. by Matthew D. Gregory (19929096)

“…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”

PCAIs suppress 3D NCI-H23 cell invasion. by Matthew D. Gregory (19929096)

“…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”

PCAIs suppress NCI-H23 cancer cell migration. by Matthew D. Gregory (19929096)

“…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”

PCAIs induce apoptosis in NCI-H23 cells. by Matthew D. Gregory (19929096)

“…However, CRAF/RAF1 phosphorylation decreased by 40%, suggesting significant changes in the KRAS/MAPK signaling patterns. …”

Visual motor response assay at 28 dpf. by Morgan Barnes (7876373)

“…(E-H) VMR parameters in dnVDRa induced zebrafish at 48 hpf. There is a significant decrease in distance moved in the dark period (p < 0.05), a significant decrease in velocity in the dark (p < 0.05) and light (p < 0.01) periods, a significant decrease in activity state in the dark period (p < 0.001) and light period (p < 0.01) and a significant decrease in distance to point in the dark period (p < 0.05) and light period (p < 0.05) in the 48 + fish. …”

Table1_Safety evaluation of medroxyprogesterone acetate: a pharmacovigilance analysis using FDA adverse event reporting system data.DOCX by Luyang Su (20411552)

“…Unforeseen significant AEs such as unintended pregnancy (n = 623; ROR, 6.65; ROR025, 6.1; χ², 2,482.38; PRR, 6.41; EBGM, 5.69; EBGM05, 5.29), bone pain (n = 35; ROR, 13.78; ROR025, 9.4; χ², 311.2; PRR, 13.75; EBGM, 10.59; EBGM05, 7.69), gait disturbance (n = 34; ROR, 2.82; ROR025, 1.99; χ², 37.31; PRR, 2.88; EBGM, 2.7; EBGM05, 2.02), dental caries (n = 15; ROR, 23.16; ROR025, 12.32; χ², 204.26; PRR, 23.14; EBGM, 15.23; EBGM05, 8.98), decrease in blood pressure (n = 15; ROR, 3.88; ROR025, 2.29; χ², 29.35; PRR, 3.88; EBGM, 3.63; EBGM05, 2.33), and osteonecrosis (n = 9; ROR, 23.44; ROR025, 10.36; χ², 123.67; PRR, 23.43; EBGM, 15.35; EBGM05, 7.75) were identified as AEs that were not previously outlined in the prescribing information of the medication.…”

Table1_Safety evaluation of medroxyprogesterone acetate: a pharmacovigilance analysis using FDA adverse event reporting system data.DOCX by Luyang Su (20411552)

“…Unforeseen significant AEs such as unintended pregnancy (n = 623; ROR, 6.65; ROR025, 6.1; χ², 2,482.38; PRR, 6.41; EBGM, 5.69; EBGM05, 5.29), bone pain (n = 35; ROR, 13.78; ROR025, 9.4; χ², 311.2; PRR, 13.75; EBGM, 10.59; EBGM05, 7.69), gait disturbance (n = 34; ROR, 2.82; ROR025, 1.99; χ², 37.31; PRR, 2.88; EBGM, 2.7; EBGM05, 2.02), dental caries (n = 15; ROR, 23.16; ROR025, 12.32; χ², 204.26; PRR, 23.14; EBGM, 15.23; EBGM05, 8.98), decrease in blood pressure (n = 15; ROR, 3.88; ROR025, 2.29; χ², 29.35; PRR, 3.88; EBGM, 3.63; EBGM05, 2.33), and osteonecrosis (n = 9; ROR, 23.44; ROR025, 10.36; χ², 123.67; PRR, 23.43; EBGM, 15.35; EBGM05, 7.75) were identified as AEs that were not previously outlined in the prescribing information of the medication.…”

Supplementary file 1_The action of ginsenoside Rg1 in patients with carotid atherosclerosis: a controlled clinical trial.docx by Xu Fang (450501)

“…Group 3 received the same treatment as Group 2, but with Bayaspirin replaced by ginsenoside Rg1 (n = 41). This study adopted a single-blind design: by uniformly encapsulating the tablets in their original form in blind bags, the subjects took them at regular intervals and in fixed quantities There were no significant differences in baseline characteristics among the groups before treatment (P > 0.05). …”

A study of the mediating role of bedtime music in employment anxiety and sleep quality among college students DATA.xl by Xu Qiujian (19715689)

“…Specifically, β decreased from 0.583 to 0.53, and T decreased from 25.717 to 22.91 Nevertheless, employment anxiety still exhibited a substantial impact on sleep quality (β = 0.53; T = 22.91; P < 0.001).Conclusion: This study concludes that employment-related anxiety has a positive and significant effect on sleep quality. …”

Table 5_Symptoms and sleep characteristics of tic disorder children with allergic diseases: a case–control study.docx by Zhang Panpan (22335250)

“…Allergic diseases also have a significant impact on children's sleep. Regrettably, it remains unclear whether TD children with comorbid allergic diseases exhibit distinct symptoms and sleep characteristics.…”

Table 3_Symptoms and sleep characteristics of tic disorder children with allergic diseases: a case–control study.docx by Zhang Panpan (22335250)

“…Allergic diseases also have a significant impact on children's sleep. Regrettably, it remains unclear whether TD children with comorbid allergic diseases exhibit distinct symptoms and sleep characteristics.…”

Table 1_Symptoms and sleep characteristics of tic disorder children with allergic diseases: a case–control study.docx by Zhang Panpan (22335250)

“…Allergic diseases also have a significant impact on children's sleep. Regrettably, it remains unclear whether TD children with comorbid allergic diseases exhibit distinct symptoms and sleep characteristics.…”

Table 6_Symptoms and sleep characteristics of tic disorder children with allergic diseases: a case–control study.docx by Zhang Panpan (22335250)

“…Allergic diseases also have a significant impact on children's sleep. Regrettably, it remains unclear whether TD children with comorbid allergic diseases exhibit distinct symptoms and sleep characteristics.…”

Table 2_Symptoms and sleep characteristics of tic disorder children with allergic diseases: a case–control study.docx by Zhang Panpan (22335250)

“…Allergic diseases also have a significant impact on children's sleep. Regrettably, it remains unclear whether TD children with comorbid allergic diseases exhibit distinct symptoms and sleep characteristics.…”

Table 4_Symptoms and sleep characteristics of tic disorder children with allergic diseases: a case–control study.docx by Zhang Panpan (22335250)

“…Allergic diseases also have a significant impact on children's sleep. Regrettably, it remains unclear whether TD children with comorbid allergic diseases exhibit distinct symptoms and sleep characteristics.…”